Calidi Biotherapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-12-31
|
-0.21
|
0.00
|
0.21
|
100.00%
|
|
2023-09-30
|
-0.17
|
-0.14
|
0.03
|
17.65%
|
|
2023-06-30
|
0.00
|
-0.43
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.23
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.26
|
-0.26
|
0.00%
|
|
2022-09-30
|
0.00
|
0.02
|
0.02
|
0.00%
|
|
2022-06-30
|
0.00
|
0.14
|
0.14
|
0.00%
|
|
2022-03-31
|
0.00
|
0.05
|
0.05
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-0.80
|
|
2022-12-31
|
-0.05
|
|
2021-12-31
|
0.12
|